Bruno Allolio

Q: What Schools Are Affiliated With Bruno Allolio

Bruno Allolio is affiliated with the following schools: University of Freiburg, University of Cologne, University of Birmingham, University of Turin, University of Würzburg

Bruno Allolio's AcademicInfluence.com Rankings

Bruno Allolio

Biology

#8203

World Rank

#11242

Historical Rank

Endocrinology

#88

World Rank

#99

Historical Rank

biology Degrees

Download Badge

Biology

Bruno Allolio's Degrees

Doctorate Medicine University of Würzburg

Why Is Bruno Allolio Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bruno Allolio's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. (2016) (987)
Erratum to: Clinical practice guideline on diagnosis and treatment of hyponatraemia (2014) (701)
Clinical review: Adrenocortical carcinoma: clinical update. (2006) (676)
Dehydroepiandrosterone replacement in women with adrenal insufficiency. (1999) (611)
Adjuvant mitotane treatment for adrenocortical carcinoma. (2007) (544)
Integrated genomic characterization of adrenocortical carcinoma (2014) (519)
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension (2013) (464)
AME position statement on adrenal incidentaloma. (2011) (440)
Mutations in the deubiquitinase gene USP8 cause Cushing's disease (2014) (412)
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma (2009) (409)
Clinical practice guideline on diagnosis and treatment of hyponatraemia (2014) (364)
Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. (1992) (354)
Adrenocortical carcinoma: a clinician's update (2011) (349)
Update in adrenocortical carcinoma. (2013) (332)
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. (2014) (320)
Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors (2011) (307)
Consensus statement on the diagnosis, treatment and follow‐up of patients with primary adrenal insufficiency (2014) (307)
The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. (2012) (293)
Clinical management of adrenocortical carcinoma. (2009) (288)
Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure (2007) (280)
Combination chemotherapy in advanced adrenocortical carcinoma. (2012) (275)
Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. (2010) (273)
High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. (2015) (272)
Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. (2007) (250)
Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. (2010) (247)
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. (2015) (244)
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism (2012) (242)
Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma (2014) (240)
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. (2009) (239)
DIURNAL SALIVARY CORTISOL PATTERNS DURING PREGNANCY AND AFTER DELIVERY: RELATIONSHIP TO PLASMA CORTICOTROPHIN‐RELEASING‐HORMONE (1990) (227)
p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. (1994) (215)
Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry (2012) (211)
High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. (2010) (207)
Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. (2006) (205)
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. (2002) (201)
Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. (1998) (199)
Adrenal Venous Sampling: Evaluation of the German Conn's Registry (2011) (195)
THE CORTICOTROPHIN RELEASING HORMONE TEST IN LATE PREGNANCY: LACK OF ADRENOCORTICOTROPHIN AND CORTISOL RESPONSE * (1990) (194)
Copeptin in the differential diagnosis of hyponatremia. (2008) (186)
Physiological and psychological effects of Hatha-Yoga exercise in healthy women. (1994) (183)
RAISED PLASMA METENKEPHALIN IN PATIENTS WHO HABITUALLY MUTILATE THEMSELVES (1983) (174)
KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism (2012) (171)
Extensive expertise in endocrinology. Adrenal crisis. (2015) (167)
Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high‐level amplifications (2000) (165)
Radiotherapy in adrenocortical carcinoma (2009) (164)
Cortisol response to corticotropin and survival in septic shock (1991) (161)
Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree (2011) (160)
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study. (2011) (159)
Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. (2012) (155)
DHEA treatment: myth or reality? (2002) (154)
Adrenal insufficiency. (2003) (152)
The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. (1993) (146)
Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. (1990) (146)
Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements (2006) (145)
Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells. (2015) (145)
Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. (2001) (145)
Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. (1999) (144)
Impact of Lymphadenectomy on the Oncologic Outcome of Patients With Adrenocortical Carcinoma (2012) (142)
Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. (2003) (141)
Clonal composition of human adrenocortical neoplasms. (1994) (138)
Influence of hydrocortisone dosage scheme on health‐related quality of life in patients with adrenal insufficiency (2010) (134)
Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. (2008) (134)
Merits and pitfalls of mifepristone in Cushing's syndrome. (2009) (134)
β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma (2010) (132)
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trial. (2012) (132)
Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. (2008) (131)
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. (2013) (130)
The role of surgery in the management of recurrent adrenocortical carcinoma. (2013) (128)
Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome--revisiting the direct and indirect water deprivation tests. (2011) (127)
The 'incidentaloma' of the pituitary gland. Is neurosurgery required? (1990) (125)
Adrenal tumors: How to establish malignancy? (2004) (120)
Development of a non-extracted 'two-site' immunoradiometric assay for corticotropin utilizing extreme amino- and carboxy-terminally directed antibodies. (1984) (119)
Does Leptin Have an Effect on Bone in Adult Women? (1998) (119)
Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. (2013) (116)
Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel. (2010) (115)
Congenital isolated adrenocorticotropin deficiency: an underestimated cause of neonatal death, explained by TPIT gene mutations. (2005) (115)
Adrenal incidentalomas: a manifestation of the metabolic syndrome? (1996) (114)
Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. (2010) (114)
Mifepristone (RU 486) in Cushing's syndrome. (2007) (114)
Management of adrenocortical carcinoma (2004) (113)
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. (2014) (111)
Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma. (2010) (111)
No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. (1995) (108)
Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. (2015) (108)
Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis. (1997) (107)
EFFECT OF A SINGLE BOLUS OF ETOMIDATE UPON EIGHT MAJOR CORTICOSTEROID HORMONES AND PLASMA ACTH (1985) (106)
ACTH-receptor expression, regulation and role in adrenocortial tumor formation. (2001) (105)
MEN1 gene analysis in sporadic adrenocortical neoplasms. (1999) (105)
Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. (1991) (103)
Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. (2001) (101)
Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. (2012) (101)
New targets and therapeutic approaches for endocrine malignancies. (2009) (101)
Gorham‐Stout Disease—Stabilization During Bisphosphonate Treatment (2004) (100)
Pituitary-interrenal interaction in zebrafish interrenal organ development. (2007) (96)
Reverse Epidemiology in Systolic and Nonsystolic Heart Failure: Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors (2009) (96)
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. (2015) (96)
TP53 germline mutations in adult patients with adrenocortical carcinoma. (2012) (95)
5-HT1A Receptor Function in Normal Subjects on Clinical Doses of Fluoxetine: Blunted Temperature and Hormone Responses to Ipsapirone Challenge (1999) (94)
Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. (2008) (91)
Erdheim-Chester disease: evidence for a disease entity different from Langerhans cell histiocytosis? Three cases with detailed radiological and immunohistochemical analysis. (2000) (90)
Evaluation of adrenal masses in oncologic patients: dynamic contrast-enhanced MR vs CT. (1991) (90)
Discerning malignancy in adrenocortical tumors: are molecular markers useful? (2001) (89)
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. (2014) (89)
Dhea Replacement in Women with Adrenal Insufficiency—Pharmacokinetics, Bioconversion and Clinical Effects on Well-Being, Sexuality and Cognition (2000) (88)
Octreotide LAR® treatment throughout pregnancy in an acromegalic woman (2001) (86)
Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. (1987) (85)
No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. (2005) (84)
Adrenal insufficiency (2003) (84)
Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma (2011) (83)
Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma. (2015) (81)
Adrenocortical carcinoma -- improving patient care by establishing new structures. (2006) (80)
High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. (2008) (79)
Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. (2006) (78)
Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. (2016) (78)
A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. (1987) (77)
High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. (2003) (76)
Effect of testosterone on post-myocardial infarction remodeling and function. (2003) (76)
Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21‐hydroxylase deficiency than in patients with primary adrenal insufficiency (2011) (76)
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. (2011) (74)
[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. (2008) (74)
Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma. (2009) (74)
Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. (1994) (72)
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. (2010) (70)
Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. (2003) (66)
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer (2012) (66)
Adrenal vein sampling for Primary Aldosteronism: time for a reality check (2010) (64)
PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit (2014) (63)
Androgen Receptor–Mediated Regulation of the &agr;-Subunit of the Epithelial Sodium Channel in Human Kidney (2005) (63)
LONG-TERM ETOMIDATE AND ADRENOCORTICAL SUPPRESSION (1983) (63)
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. (2012) (63)
Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. (2009) (63)
Low circulating androgens and mortality risk in heart failure (2009) (63)
N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. (2003) (61)
Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. (2006) (61)
Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. (2014) (60)
Reverse Epidemiology in Systolic and Nonsystolic Heart FailureCLINICAL PERSPECTIVE (2009) (60)
Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence? (2013) (60)
Risk Factors for Hip Fracture Not Related to Bone Mass and Their Therapeutic Implications (1999) (59)
[131I]iodometomidate for targeted radionuclide therapy of advanced adrenocortical carcinoma. (2012) (59)
Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency. (2013) (59)
Adrenocortical suppression by a single induction dose of etomidate (1984) (59)
Deficits in the management of patients with adrenocortical carcinoma in Germany. (2010) (58)
Management of hypoparathyroidism during pregnancy--report of twelve cases. (1998) (58)
Therapeutic management of adrenal insufficiency. (2009) (58)
p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan. (1996) (58)
Prognostic impact of subclinical thyroid dysfunction in heart failure. (2013) (57)
DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. (1998) (55)
Alendronate Increases Bone Density and Bone Strength at the Distal Radius in Postmenopausal Women (1999) (53)
Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. (1998) (52)
Dysnatraemia in heart failure (2012) (52)
Antiproliferative and angiostatic activity of suramin analogues. (1995) (52)
Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in cushing's syndrome (1988) (52)
Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. (1998) (51)
Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms (2001) (51)
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients (2012) (50)
Multicenter German reference data base for peripheral quantitative computer tomography. (1995) (50)
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma (2013) (49)
Determinants of Radial Bone Density as Measured by PQCT in Pre‐ and Postmenopausal Women: The Role of Bone Size (1997) (49)
SELECTIVE BILATERAL AND SIMULTANEOUS CATHETERIZATION OF THE INFERIOR PETROSAL SINUS: CRF STIMULATES PROLACTIN SECRETION FROM ACTH‐PRODUCING MICROADENOMAS IN CUSHING'S DISEASE (1988) (48)
Management of adrenal insufficiency in different clinical settings (2005) (47)
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line (2000) (47)
Influence of Short-Term Glucocorticoid Therapy on Regulatory T Cells In Vivo (2011) (47)
Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome (2010) (47)
A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresis. (2014) (47)
The pro-opiomelanocortin gene of the zebrafish (Danio rerio). (2003) (46)
Timelines in the management of adrenal crisis – targets, limits and reality (2015) (46)
Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion. (1982) (44)
Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5??-reductase Activity in Women With Polycystic Ovary Syndrome (2003) (44)
What is the best approach to an apparently nonmetastatic adrenocortical carcinoma? (2010) (44)
AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors. (2005) (43)
Frequency and frequently overlooked: Treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors (1997) (43)
Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT. (2013) (43)
Drinking water fluoridation: bone mineral density and hip fracture incidence. (1998) (42)
Adrenocortical function in patients with macrometastases of the adrenal gland. (2000) (41)
Bariatric surgery for morbid obesity in craniopharyngioma (2013) (41)
Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy. (2009) (40)
Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging. (2005) (40)
Susceptibility to Cardiac Ischemia/Reperfusion Injury Is Modulated by Chronic Estrogen Status (2002) (39)
Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP. (2006) (39)
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma (2014) (39)
Age at menarche and cortical bone geometry in premenopausal women. (1999) (38)
Ectopic ACTH production by a bronchial carcinoid tumour responsive to desmopressin in vivo and in vitro (1997) (38)
High-dose 17β–estradiol treatment prevents development of heart failure post–myocardial infarction in the rat (2006) (38)
Computed tomography criteria for discrimination of adrenal adenomas and adrenocortical carcinomas: analysis of the German ACC registry. (2015) (38)
Steroidogenic acute regulatory protein mRNA expression in adrenal tumours. (2000) (37)
[Reproducibility of bone density measurements of the distal radius using a high resolution special scanner for peripheral quantitative computed tomography (Single Energy PQCT)]. (1992) (36)
Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways. (2012) (36)
Effect of meclastine, an H1-antihistamine, on plasma ACTH in adrenal insufficiency. (1981) (36)
The syndrome of inappropriate secretion of antidiuretic hormone: diagnostic and therapeutic advances. (2010) (36)
Metastatic adrenocortical carcinoma: results of 56 pulmonary metastasectomies in 24 patients. (2011) (36)
Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with alpha-cyclodextrin and glycine. (2003) (35)
Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma. (2013) (35)
Low SGK1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis (2012) (34)
Aminoglutethimide suppresses adrenocorticotropin receptor expression in the NCI-h295 adrenocortical tumor cell line. (1998) (34)
FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease. (1986) (33)
Impairment of 11β-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas' (1997) (33)
Assessment of serum‐free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study (2010) (33)
Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. (2006) (32)
Mineralocorticoid substitution and monitoring in primary adrenal insufficiency. (2015) (31)
Urinary Adiponectin Excretion (2009) (31)
Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells (2011) (31)
The adrenal secretory serine protease AsP is a short secretory isoform of the transmembrane airway trypsin-like protease. (2004) (31)
Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling. (1999) (30)
Dehydroepiandrosterone replacement therapy (2001) (30)
The stress response to laparoscopic cholecystectomy: investigation of endocrine parameters. (1994) (30)
[Incidence of femoral neck fractures in the German Federal Republic in comparison to other countries]. (1994) (30)
Telomerase activity in benign and malignant adrenal tumors. (2009) (29)
Endothelial capillaries chemotactically attract tumour cells (2001) (29)
Influence of oral dehydroepiandrosterone (DHEA) on urinary steroid metabolites in males and females (2000) (29)
DHEA: why, when, and how much--DHEA replacement in adrenal insufficiency. (2007) (29)
Suramin in adrenocortical cancer: limited efficacy and serious toxicity (1994) (29)
Reduced lymphocyte β2‐adrenoceptor density and impaired diastolic left ventricular function in patients with glucocorticoid deficiency (1994) (28)
Intraoperative haemodynamic stability in patients with phaeochromocytoma – minimally invasive vs conventional open surgery (2006) (27)
[¹²³I]Iodometomidate imaging in adrenocortical carcinoma. (2013) (27)
Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome. (2015) (26)
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism. (2015) (26)
Suramin treatment in hormone- and chemotherapy-refractory prostate cancer. (1999) (26)
A multihormonal response to corticotropin-releasing hormone in inferior petrosal sinus blood of patients with Cushing's disease. (1990) (26)
The New Molecular Landscape of Cushing's Disease (2015) (26)
Drinking water fluoridation and bone. (2009) (25)
Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas (2000) (25)
Dual-energy X-ray absorptiometry at the lumbar spine in German men and women: A cross-sectional study (1995) (25)
Testosterone undecanoate: a useful tool for testosterone administration in rats. (2003) (25)
Apparent velocity of ultrasound (AVU) at the patella in comparison to bone mineral density at the lumbar spine in normal males and females. (1993) (24)
The 'Incidentaloma' of the Pituitary Gland (2016) (24)
Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. (2000) (24)
[123I]Iodometomidate imaging in adrenocortical carcinoma (2013) (24)
Occult eutopic Cushing's syndrome--failure of simultaneous bilateral petrosal sinus sampling to diagnose pituitary-dependent Cushing's syndrome. (1997) (23)
Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa). (2014) (23)
Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects (1996) (23)
Bone Mineral Density in Athletes of Different Disciplines: a Cross- Sectional Study (2014) (23)
Bone mineral density in top level male athletes of different sports (2001) (22)
Cushing's syndrome due to an ectopic ACTH‐secreting pituitary tumour mimicking occult paraneoplastic ectopic ACTH production (1999) (22)
Epidemiology of Adrenocortical Carcinoma (2009) (22)
The “Incidentaloma” of the Pituitary Gland: Is Neurosurgery Required? (1990) (21)
Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects (1995) (21)
VALPROATE IN CUSHING'S SYNDROME (1982) (21)
Erratum: Clinical practice guideline on diagnosis and treatment of hyponatraemia (European Journal of Endocrinology 170 (G1-G47)) (2014) (21)
Adjuvant mitotane for adrenocortical cancer--working through uncertainty. (2009) (20)
Sex-specific regulation of ENaC and androgen receptor in female rat kidney. (2009) (20)
Preclinical Cushing's syndrome in adrenal incidentalomas (1992) (19)
High evening salivary cortisol is an independent predictor of increased mortality risk in patients with systolic heart failure. (2016) (19)
Hypogonadism in Rhodesian sleeping sickness: evidence for acute and chronic dysfunction of the hypothalamic-pituitary-gonadal axis. (1996) (18)
[Etomidate versus etomidate and hydrocortisone for anesthesia induction in abdominal surgical interventions]. (1988) (18)
High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat. (2007) (18)
DHEA replacement in adrenal insufficiency. (2003) (18)
Evidence against a role of human airway trypsin-like protease--the human analogue of the growth-promoting rat adrenal secretory protease--in adrenal tumourigenesis. (2005) (18)
Severe Illness (1995) (17)
Survivin in Adrenocortical Tumors – Pathophysiological Implications and Therapeutic Potential (2012) (16)
Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family. (2002) (16)
SURAMIN FOR TREATMENT OF ADRENOCORTICAL CARCINOMA (1989) (16)
Precision of dual x-ray absorptiometry and peripheral computed tomography using mobile densitometry units (1994) (16)
Effect of adrenergic antagonism on the growth hormone, prolactin and cortisol response to a synthetic opioid agonist in man. (1986) (16)
A Dangerous Liaison—Pheochromocytoma in Patients with Malignant Disease (2006) (16)
Prognostic value of aldosterone and cortisol in patients hospitalized for acutely decompensated chronic heart failure with and without mineralocorticoid receptor antagonism. (2015) (16)
Clinical practice guideline on diagnosis and treatment of hyponatraemia (vol 40, pg 320, 2014) (2014) (16)
Fatal toxic epidermal necrolysis during suramin therapy. (1991) (15)
Dehydroepiandrosterone to enhance physical performance: myth and reality. (2010) (15)
EFFECTS OF HIGH‐DOSE AND LOW‐DOSE NALOXONE ON PLASMA ACTH IN PATIENTS WITH ACTH HYPERSECRETION (1985) (15)
Expression of HER-2/neu receptor protein in adrenal tumors. (2002) (15)
Detrimental effects of testosterone on post-myocardial infarction remodelling in female rats. (2007) (15)
Osteopontin stimulates invasion of NCI‐h295 cells but is not associated with survival in adrenocortical carcinoma (2009) (14)
A woman who gained weight and became schizophrenic (2002) (14)
Intracellular free amino acid patterns in duodenal and colonic mucosa. (1990) (14)
EFFECT OF MECLASTINE, A SELECTIVE H1 RECEPTOR ANTAGONIST, UPON ACTH RELEASE (1983) (14)
Addisonian crisis in a young man with atypical anorexia nervosa (2011) (13)
High incidence of hyponatremia in rowers during a four-week training camp. (2015) (13)
Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency (2013) (13)
Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing's syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF. (1987) (13)
[Current TNM classification systems for adrenocortical carcinoma]. (2010) (13)
Improved metabolic control after 12-week dietary intervention with low glycaemic isomalt in patients with type 2 diabetes mellitus. (2009) (13)
Urinary adiponectin in type 2 diabetes Urinary Adiponectin Excretion : A Novel Marker for Vascular Damage in Type 2 Diabetes Running title : Urinary adiponectin in type 2 diabetes (2009) (13)
Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus in the Russian population. (1997) (13)
Etomidate unmasks intraadrenal regulation of steroidogenesis and proliferation in adrenal cortical cell lines. (2010) (13)
Adrenocorticotropin receptor and adrenal disorders. (1997) (12)
Adrenocortical carcinoma in a patient with untreated congenital adrenal hyperplasia (CAH) (1988) (12)
[With safety in danger]. (1996) (12)
[Adrenal crisis. Diagnostic and therapeutic management of acute adrenal cortex insufficiency]. (2003) (12)
Adjuvant radiation therapy of the tumor bed prevents local recurrences in adrenocortical carcinoma (2006) (12)
Size heterogeneity of immunoreactive prolactin in patients with prolactinoma. (1987) (12)
[Adrenocortical carcinoma. Diagnostic work-up and treatment]. (2008) (12)
Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy. (1999) (11)
Multiple mechanisms are involved in the acute vasodilatory effect of 17beta-estradiol in the isolated perfused rat heart. (1999) (11)
Hyponatraemia diagnosis and treatment clinical practice guidelines. (2017) (11)
Prognostic value of histological markers in localized adrenocortical carcinoma after complete resection (2013) (11)
[German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment]. (2012) (11)
[Treatment of sex behavior disorders with LH-RH superagonists]. (1985) (11)
The hypothalamic-pituitary-adrenal axis in critical illness (1993) (11)
Bone Mineral Density in Athletes of Different Disciplines: a Cross- Sectional Study~!2010-04-09~!2010-06-28~!2010-08-13~! (2010) (10)
Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'. (1997) (10)
High-dose progesterone infusion in healthy males: evidence against antiglucocorticoid activity of progesterone. (1995) (10)
Correction: Clinical practice guideline on diagnosis and treatment of hyponatraemia (vol 170, pg G1, 2014) (2014) (10)
Clodronate inhibits adrenocortical cell proliferation and P450c21 activity. (2002) (10)
P53 mutations in human adrenocortical neoplasms (1994) (9)
Androgen Deficiency in Heart Failure (2011) (9)
The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease (1988) (9)
Primary cortisol resistance as a differential diagnosis of Cushing's syndrome (1989) (9)
Silencing of the mineralocorticoid receptor by ribonucleic acid interference in transgenic rats disrupts endocrine homeostasis. (2008) (9)
Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas (2016) (8)
Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study. (2017) (8)
Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma. (2014) (8)
CONTINUOUS INFUSION OF GROWTH HORMONE RELEASING HORMONE DOES NOT ALTER THE GROWTH HORMONE RESPONSE TO DIFFERENT STRESS STIMULI (1986) (8)
Prevalence of Malignancies in Patients With Primary Aldosteronism. (2016) (8)
Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper‐responsiveness of hypothalamo–pituitary–adrenal axis in patients with adrenal incidentalomas (2000) (8)
Cyproheptadine inhibits the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects. (1987) (7)
Velocity of ultrasound at the patella: Influence of age, menopause and estrogen replacement therapy (1993) (7)
Sleep quality in patients with primary aldosteronism. (2013) (7)
Effects of etomidate on adrenocortical function (1984) (7)
[Assessment of nutritional status--a part of routine clinical diagnosis: cholinesterase activity as a nutritional indicator]. (1989) (6)
[Molecular biology of incidentally diagnosed adrenal gland space-occupying lesion]. (1997) (6)
Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population. (2009) (6)
Overestimation of osteopenia using standard analysis software for peripheral quantitative computed tomography (1993) (6)
[Coccidioidomycosis--differential diagnosis of lung infiltrates with peripheral eosinophilia]. (1989) (6)
Low SGK 1 Expression in Human Adrenocortical Tumors Is Associated with ACTH-Independent Glucocorticoid Secretion and Poor Prognosis (2012) (5)
EXERCISE OXIMETRY FOR EARLY DIAGNOSIS OF PNEUMOCYSTIS CARINII PNEUMONIA (1989) (5)
Deutsches Nebennierenrindenkarzinom-Register (2012) (5)
Hypertension and hypertensive cardiomyopathy in patients with a relapse‐free history of phaeochromocytoma (2015) (4)
[Vascular risk factors in patients with ophthalmoplegia]. (1990) (4)
Cumulative Prognostic Benefit of Classical Cardiovascular Risk Factors (2009) (4)
Influence of short-term glucocorticoid therapy on regulatory T cells (2010) (4)
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly. (2011) (4)
Dehydroepiandrosterone substitution in women. (1999) (4)
[The Gitelman syndrome--a differential diagnosis of Bartter syndrome]. (1994) (4)
Impact of surgery on clinical outcome in patients with recurrence of adrenocortical carcinoma (2009) (4)
Replacement of serum cortisol determination by measurements of cortisol in saliva (1984) (4)
Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma: preliminary results from the first international phase III trial: the FIRM-ACT study (2011) (4)
[Cortisol plasma concentration in patients with primary adrenal cortex insufficiency during substitution therapy with cortisone acetate]. (1978) (4)
Reply to Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma (2009) (3)
[Bilateral massive macronodular adrenal gland hyperplasia. A rare cause of Cushing's syndrome]. (1994) (3)
Dehydroepiandrosterone (DHEA) and androstenedione (2001) (3)
Changes in biomechanical properties of rat femora induced by ovariectomy as analyzed by pQCT (2006) (3)
The effect of prostacyclin on pituitary hormone release. (1980) (3)
Dehydroepiandrosterone supplementation in elderly men: the role of estrogens versus androgens on the male skeleton. (2002) (3)
Regulation of the pituitary-adrenal-axis in late pregnancy: ACTH and cortisol secretion in response to synthetic human corticotropin-releasing hormone (1988) (3)
Epidermal growth factor receptor (EGFR) as a potential new target in the treatment of patients with adrenocortical carcinoma – results of pre-clinical studies (2007) (3)
[Alcohol-induced Cushing's syndrome: case report (author's transl)]. (1980) (3)
[Visceral leishmaniasis contracted in Europe (kala-azar)]. (1990) (3)
Suspected metastatic adrenocortical carcinoma revealing as pulmonary Kaposi sarcoma in adrenal Cushing’s syndrome (2014) (3)
[Simultaneous bilateral catheterization of the inferior petrosal sinus in Cushing's syndrome. ACTH determination for the diagnosis and location of the side of a hypophyseal microadenoma before and after administration of corticotropin-releasing hormone]. (1987) (3)
Sunitinib in refractory adrenocortical carcinoma: results of a phase II trial (2011) (3)
Do mitotane levels impact on the outcome of patients treated adjuvantly following radical resection of adrenocortical cancer (ACC) (2011) (3)
Naloxone in treatment of circulatory shock resistant to conventional therapy (1987) (3)
The pituitary-adrenal-axis in renal insufficiency: evidence for glucocorticoid resistance (1989) (3)
Increased activity of the Na-K-ATPase in red cell-ghosts of patients with Cushing's Syndrome: Possible significance for the pathogenesis of glucocorticoid-induced hypertension (1980) (3)
Adrenal crisis and general morbidity in chronic adrenal insufficiency prospectively assessed in 472 patients (2011) (3)
A novel theranostic concept for Adrenocortical Neoplasia targeting the chemokine receptor CXCR4 (2015) (2)
Mitotane induces endoplasmic reticulum stress triggering apoptosis and decrease of steroid hormone synthesis (2014) (2)
[Localization of an ACTH-producing pituitary microadenoma using bilateral and simultaneous catheterization of the inferior petrosal sinus]. (1988) (2)
Infusion of beta-endorphin has no suppressive effect on the releasing hormone-stimulated pituitary-adrenal-axis of normal human subjects. (1990) (2)
Adrenocortical insufficiency in Rhodesian sleeping sickness is not attributable to suramin. (1995) (2)
[Secondary prevention of osteoporosis and identification of high risk patients]. (2000) (2)
Adrenocortical carcinoma: current and future therapeutic options (2007) (2)
[Recurrent hypertensive crises associated with severe orthostatic hypotension due to baroreflex failure syndrome]. (2002) (2)
[Treatment of metastatic adrenal carcinoma with suramin]. (1989) (2)
Frequency and causes of adrenal crises over life-time in patients with 21-hydroxylase deficiency (2012) (2)
[Leser-Trélat syndrome]. (1989) (2)
The zebrafish as a model organism to study adrenal development (2004) (2)
Constitutive activation of PRKACA in adrenal Cushing's syndrome (2014) (2)
Mortality risk prediction by cortisol and aldosterone in chronic heart failure (2007) (2)
Understanding polycystic ovarian syndrome. (2005) (2)
Successful treatment of two patients with refractory hypoparathyroidism by continuous subcutaneous administration of recombinant PTH (1 – 34) (2015) (2)
Diagnostische Probleme beim ektopen Cushing-Syndrom (1988) (2)
Adrenal crisis in primary and secondary adrenal insufficiency: frequency and causes (2008) (2)
Physiological area of normality of copeptin in normal-to-hyperosmolar states (2015) (2)
Erratum to: Clinical practice guideline on diagnosis and treatment of hyponatraemia (2014) (2)
[Unrecognized primary hyperparathyroidism in simultaneous presence of insulin-dependent diabetes mellitus. Joint occurrence of parathyroid adenoma, type I diabetes mellitus, Basedow disease, pernicious anemia and stomach carcinoid]. (1988) (2)
Nomifensine‐induced immune hemolytic anemia and posttransfusion purpura in the same patient (1987) (2)
131I-Iodometomidate radiotherapy for metastatic adrenocortical carcinoma: first clinical experience (2009) (2)
[Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide]. (1987) (2)
Copeptin in the diagnosis and differential diagnosis of diabetes dnsipidus - the 'CoSIP-study' (2014) (2)
Bone fragility in comparison to distal forearm Bone mineral density in perimenopausal women (1992) (2)
[Obesity and heart failure]. (2008) (2)
Mitotane inhibits sterol-o-acyltransferase leading to lipid-mediated endoplasmic reticulum stress and apoptosis of adrenocortical carcinoma cells (2015) (2)
The effect of β-endorphin-infusion on releasing hormone-stimulated anterior pituitary hormone secretion in normal human subjects (1989) (2)
673 Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure (2007) (2)
DHEA replacement in adrenal insufficiency. Authors' reply (2003) (2)
Renal expression of alpha-ENaC is increased in testosterone treated rats (2006) (2)
Amino acid determination of human intestinal mucosa obtained by endosopic biopsies (1990) (2)
Reply to letter: "regional lymphadenectomy for adrenocortical carcinoma". (2013) (2)
[123/131I](R)-1-[1-(4-iodophenyl)ethyl]-1H-imidazole-5-carboxylic acid azetidinylamide (IMAZA) – A novel radiotracer for diagnosis and treatment of adrenocortical tumours – From bench to bedside (2015) (2)
Early development of a celiac trunk aneurysm during anti-vascular endothelial growth factor receptor therapy. (2014) (2)
Inhibitory action of cyproheptadine on corticotrophin-releasing hormone (CRH)-induced hormone release (1987) (2)
CT criteria for adrenal cancer - analysis of the German ACC registry (2013) (2)
[Replacement therapy with adrenal steroids]. (2008) (2)
[Paraneoplastic hypertrichosis lanuginosa et terminalis in a 27-year old woman with parotid carcinoma]. (1999) (1)
High incidence of hyponatremia in trained rowers during a four-week training camp (2015) (1)
[ 123 I]Iodometomidate as a radiotracer for adrenal scintigraphy first clinical experience (2007) (1)
[Suramin--a new therapeutic principle in the treatment of metastatic adrenal gland cancer]. (1990) (1)
Opioidergic Control of the Pituitary-Adrenal Axis (1990) (1)
Failure of recombinant human growth hormone treatment to improve congestive heart failure in hypopituitarism. (2004) (1)
[Diagnosis and therapy of asymptomatic adrenal tumors]. (1989) (1)
THE ADRENAL VEIN SAMPLING INTERNATIONAL STUDY (AVIS) ON USE AND INTERPRETATION OF ADRENAL VEIN SAMPLING FOR DIFFERENTIATING THE MAJOR SUBTYPES OF PRIMARY ALDOSTERONISM: 8D.07 (2011) (1)
Etomidate-induced inhibition of adrenal steroidogenesis is not reversed by exogenously administered ascorbic acid (1990) (1)
Chemokine receptor expression in the adrenal cortex and in adrenocortical tumours (2007) (1)
Prevention of hypertensive crises in rats induced by acute and chronic norepinephrine excess. (2010) (1)
Expression of CYP2W1 in the adrenal gland: relationship with hormone secretion and clinical outcome (2014) (1)
Is endoscopic adrenalectomy the treatment of choice for large primary adrenal tumors? (2006) (1)
[Severe Vitamin D(dihydrotachysterol)-intoxication with temporary anemia and hypercalcemia responsive to bisphosphonates] (2001) (1)
Epidermal growth factor receptor (EGFR) as a potential new target in the treatment of patients with adrenocortical carcinoma: Results of pre-clinical studies (2007) (1)
Management and efficacy of intensified insulin therapy — Starting in outpatients (2005) (1)
Urinary Steroid Profiling as a High-Throughput Screening Tool for the Detection of Malignancy in Patients with Adrenal Tumors (2010) (1)
[Occult ectopic Cushing's syndrome]. (1988) (1)
Hormone replacement strategies in adult endocrine disease. (2015) (1)
[Pregnancy in Addison's disease]. (1990) (1)
Testosterone: Dehydroepiandrosterone and androstenedione (2012) (1)
[Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation]. (1983) (1)
[Endocrinology update. II]. (1996) (1)
Hydrocortisone infusion after induction with etomidate in major surgery: failure to abolish the postoperative ACTH increase (1986) (1)
Sleep quality in patients with primary aldosteronism (2014) (1)
Dual Control of ACTH Secretion by Hypothalamic and Placental Corticotropin-Releasing Factor (CRF) in Late Pregnancy (1989) (1)
TP53 and adrenocortical cancer: analysis of germline mutations and polymorphic changes in 140 patients (2011) (1)
Non-hypnotic low-dose etomidate for rapid correction of hypercortisolism (1987) (1)
[ 123/131 I] azetidinylamide a novel radiotracer for diagnosis and treatment of adrenocortical tumours -- from bench to bedside (2015) (1)
Transient pregnancy-induced Cushing's Syndrome with Aberrant Adrenal hCG receptor (2014) (1)
ß-endorphin-immunoreactivity in the ventricular CSF and plasma of comatose patients (2005) (1)
High expression of C-X-C chemokine receptor type 4 in the zona glomerulosa and in aldosterone producing adenoma (2015) (1)
[Endocrinology update--I]. (1996) (1)
[Indications for measuring bone density]. (1992) (1)
Clinical Presentation and Initial Diagnosis (2009) (1)
Effect of cholinergic blockade on growth hormone response to GRF 1-29 in acromegaly after successful transsphenoidal surgery (1989) (1)
[Estrogens in menopause--therapy and prevention. III. Estrogen replacement in menopause: uses and risks in prevention and therapy of cardiovascular diseases]. (1996) (1)
Suramin in adrenocortical cancer (1994) (1)
Impaired quality of life in patients with adrenal insufficiency evidence that improved glucocorticoid replacement strategies are needed (2006) (1)
Do dehydroepiandrosterone supplements have anti-aging potential? (2007) (1)
[Role of bone histology in the determination of bone metabolism]. (2003) (1)
[Osteoporosis and nutrition]. (1996) (1)
Intestinal glutamine metabolism of patients with HIV-infection. (1990) (1)
[AIDS-related complex: a superfluous concept?]. (1990) (1)
[Bilateral salivary gland swelling with pitfalls]. (1994) (1)
Prognostic factors in localized adrenocortical carcinoma (ACC) after complete resection (2008) (0)
Direct measurement of adrenal DHEA and DHEAS secretion provides evidence for a pivotal role of extraadrenal sulphonation for peripheral DHEA availability (2006) (0)
Reply to Sebastien Gaujoux, Stephane Bonnet, Bertrand Dousset’s Letter to the Editor re: David Brix, Bruno Allolio, Wiebke Fenske, et al. Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients. Eur Urol 2010;58:609–15 (2010) (0)
Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion (1988) (0)
Differential effects of cytokines on the growth and function of normal and thyrotoxic human thyrocytes (1989) (0)
Outcome and prognostic factors in adrenocortical cancer after complete tumor resection (2006) (0)
[Osteoporosis in the male]. (2000) (0)
Single nucleotide polymorphism array profiling of adrenocortical tumors: evidence for an adenoma carcinoma sequence? (2013) (0)
Subtype differentiation in primary hyperaldosteronism: evaluation of alternative algorithms avoiding a controversial gold standard (2010) (0)
Society for Endocrinology European Medal Lecture 2010 (2011) (0)
The brazilian Arg337His germ line hot spot mutation in exon 10 of TP53 is infrequent in german patients with adrenocortical carcinoma (2006) (0)
Adrenal phenotype in TPIT insufficient animals cannot be restored by short-term treatment with physiological doses of ACTH and N-POMC (2005) (0)
Health related quality of life differs between three replacement therapies in adrenal insufficiency (2008) (0)
Suspected metastatic Adrenocortical Carcinoma revealing as Pulmonary Kaposi Sarcoma in Adrenal Cushing's syndrome (2014) (0)
[Endocrinology update. I]. (1994) (0)
Hypersecretion of a large molecular weight form of ACTH by a clinically silent pituitary adenoma (1985) (0)
Persistent Hypertension after successful resection of pheochromocytomas – results of a retrospective follow-up study (2013) (0)
Comparison of peptide hormones amd TPA as tumor markers in patients with bronchogenic carcinoma (1987) (0)
Postersession I: Endokrinologie (1984) (0)
Survivin – a promising target for immunotherapy in patients with adrenocortical carcinoma (2007) (0)
Adrenal lumps and bumps: progress in the management of adrenal tumours (2010) (0)
Adrenal crisis in patients with primary and secondary adrenal insufficiency (2006) (0)
Correction of severe tumor-induced hypercortisolism by low-dose non-hypnotic etomidate treatment: Adrenal responses in patients with cushing s̀ syndrome and normal volunteers (1987) (0)
Cardiac function in endocrine diseases: I. acromegaly (1989) (0)
[A therapeutic alternative to the economical vitamin D is the active metabolite calcitriol]. (1996) (0)
Cardiovascular complications in CKD 5D (2012) (0)
ERCC1 expression in adrenocortical carcinoma: relationship with baseline characteristics and response to platinum-based chemotherapy (2008) (0)
Adrenal (interrenal) development in the zebrafish (2006) (0)
Adrenocortical tumours: from bench to bedside and back (2014) (0)
Osteopontin (OPN) expression in adrenocortical cancer – missing effect of OPN on proliferation in vitro and survival in vivo (2007) (0)
Running title: Bevacizumab plus capecitabine in ACC (2009) (0)
Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples preparation for an European adrenal tumor bank (ENS@T) (2006) (0)
Wednesday, 29 August 2012 (2012) (0)
Inhibitor of apoptosis proteins (IAP) in adrenocortical tumors (2015) (0)
Long-term outcome of laparoscopic versus open adrenalectomy for adrenocortical carcinoma (2009) (0)
AKT is highly phosphorylated in pheochromocytomas, but not in adrenocortical tumors (2004) (0)
BIRC7/livin, a member of inhibitor of apoptosis protein (IAP) family, in adrenocortical tumors (2014) (0)
Single nucleotide polymorphism array profiling as tool to discover new candidates in diagnosis and prognosis for adrenocortical tumors (2013) (0)
Limited weight loss with gastric banding in patients with craniopharyngeoma (2010) (0)
Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome – revisiting the direct and indirect water deprivation tests (2010) (0)
The Pituitary Incidentaloma Beyond the First Year of Follow-up-Reply (1990) (0)
[A hairy case]. (1999) (0)
[Diagnostic problems in ectopic Cushing syndrome]. (1988) (0)
Translocation of beta-arrestin2 by the PTH type 2 receptor is independent from its ligand-induced cAMP signaling, phospholipase C-dependent signaling, or MAP kinase signaling (2005) (0)
Workshop B: androgens for men and women - new insights. (2003) (0)
Evaluation of hENT1 expression in adrenocortical tumors: Correlation with clinical outcome and response to gemcitabine chemotherapy (2015) (0)
Deficits in the clinical management of patients with adrenocortical carcinoma in Germany (2008) (0)
Dendritic cell based immunotherapy against adrenocortical carcinoma – screening for suitable targets (2006) (0)
The role of circulating and tumor infiltrating T-cells on clinical outcome in adrenocortical carcinoma (2012) (0)
Radiation-induced hypothalamic-pituitary damage in long term survivors of primary brain tumours is reflected by endocrine dysfunction and impaired health-related quality of life (2008) (0)
738 ONCOLOGIC OUTCOME OF LAPAROSCOPIC AND OPEN ADRENALECTOMY IN ADRENOCORTICAL CANCER: A CASE CONTROL STUDY IN 54 PATIENTS (2009) (0)
[Principles of glucocorticoid therapy from the viewpoint of the internist]. (1989) (0)
Chapter 107 – Adrenocortical Carcinoma (2016) (0)
Circulating levels of peptide hormones and TPA in patients with bronchogenic carcinoma and in benign lung disease (1988) (0)
Impaired blood glucose regulation during physical exercise in APS2 patients with combined Addison's disease and type 1 diabetes (2014) (0)
Differences in quality of life between three replacement therapies in adrenal insufficiency (2008) (0)
Copeptin for subtype differentiation of abnormal vasopressin release in SIADH: reclassification and characterization of a novel subtype (2013) (0)
Reduced 5α-reductase activity in peripheral blood mononuclear cells in polycystic ovarian syndrome a compensatory mechanism for androgen excess? (2007) (0)
Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples – preparation for an international adrenal tumor bank (2006) (0)
The new TNM classification is inferior to the Lee classification in predicting outcome in patients with adrenocortical carcinoma (2006) (0)
Quality of life in adult patients with congenital adrenal hyperplasia - results of the congenital adrenal hyperplasia adult study executive (2009) (0)
The syndrome of inappropriate antidiuresis: a copeptin-based classification and identification of a novel subtype (2014) (0)
Thyroid dysfunction in African trypanosomiasis (1993) (0)
Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types (1984) (0)
[Clinical steps in diagnosis]. (1994) (0)
[Oligosymptomatic thyrotoxic crisis and its treatment by plasmapheresis]. (1982) (0)
Adrenocortical carcinoma: advance through international cooperation (2011) (0)
Steroidogenic factor 1 - a valuable diagnostic and prognostic tool in patients with adrenocortical carcinoma (2009) (0)
PET-tracers for differential diagnosis in primary hyperaldosteronism (2012) (0)
Subject Index Vol. 47, 1997 (1997) (0)
Acknowledgement of reviewers 2013 (2014) (0)
Metabolically stabilised radiotracers for the diagnosis of adrenocortical tumours and radiotherapy of adrenal carcinoma (2013) (0)
Addison's disease: natural history and long-term outcome (2009) (0)
[Intravenous metopiron test in normal persons and patients with adrenal cortex diseases]. (1982) (0)
Sex steroid biosynthesis in human peripheral blood mononuclear cells changes with aging (2004) (0)
Testosterone treatment in rats increases expression of the alpha-subunit of the epithelial sodium channel (alpha-ENaC) in the kidney (2006) (0)
General morbidity and working capacity in patients with chronic adrenal insufficiency – A prospective study (2015) (0)
Measurement of skin thickness by ultrasound and its predictive value to indicate decreased Bone Mineral Density at the distal forearm (1992) (0)
[New diabetes therapy in clinical trial: will need adapted insulin supply be available soon? (interview by Dr. Judith Neumaier)]. (2004) (0)
Treatment of refractory adrenocortical carcinoma with thalidomide: results of a retrospective analysis of 15 patients (2014) (0)
High JAG1 expression in adrenocortical carcinomas is associated with better prognosis (2014) (0)
[Fever in HIV-1 infection]. (1989) (0)
Lack of Hepatic Conversion of Dehydroepiandrosterone Sulfate (DHEAS) to DHEA (2004) (0)
The influence of surgery in the management of recurrent adrenocortical carcinoma. (2012) (0)
Chemotherapy and radiotherapy for adrenocortical carcinoma (ACC) (2009) (0)
674 Prognostic value of androgens in male patients with chronic heart failure (2007) (0)
Fieber bei HIV-1-Infektion (2008) (0)
Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients (2006) (0)
Plasma Concentrations of o,p (cid:1) DDD, o,p (cid:1) DDA, and o,p (cid:1) DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study (2011) (0)
Expression of inhibitor of apoptosis protein BIRC7/livin in adrenocortical tumors (2014) (0)
Post saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism (2014) (0)
Quality of life (QoL) in male and female patients with congenital adrenal hyperplasia (CAH) compared to healthy subjects and patients with primary adrenal insufficiency (2009) (0)
Gel Chromatographie Charaeterization of Immunoreaetive Adrenoeortieotropin in Patients with ACTH Hyperseeretion (1989) (0)
Highly unusual association of an aneurysmal bone cyst and renal phosphate wasting in a young female patient (2004) (0)
[The dexamethasone test in the diagnosis of paraneoplastic ACTH secretion in patients with bronchial carcinoma]. (1984) (0)
Reduced androgen activation in peripheral blood mononuclear cells in polycystic ovarian syndrome – a compensatory mechanism for hyperandrogenaemia? (2007) (0)
Cortisol, DHEA and DHEAS in severe sepsis - a paradigm revisited (2005) (0)
Influence of a Met-enkephalin analogue on CRF-induced ACTH release in normal individuals and patients with Cushing's disease (1985) (0)
Differences in quality of life between twice and thrice daily application of hydrocortisone in adrenal insufficiency (2008) (0)
Inhibitor of apoptosis protein livin/BIRC7 in adrenocortical tumours (2015) (0)
Urinary steroid profiling as a biomarker tool for the detection of adrenal malignancy: results of the EURINE ACC Study (2009) (0)
Development of new improved derivatives of iodometomidate for the diagnosis of adrenocortical tumours and radiotherapy of adrenal carcinoma (2014) (0)
The Notch ligand Jagged1 is up-regulated in adrenocortical carcinomas and is associated with a favourable clinical outcome (2015) (0)
Inhibition of IGF-II signal transduction improves chemosensitivity in human adrenocortical cancer cells (2006) (0)
Plasma Concentration of o,p'DDD (Mitotane), o,p'DDA and o,p'DDE as Predictors of Tumor Response in Adrenocortical Carcinoma : Results of a Retrospective European Network for the Study of Adrenal Tumors (ENS@T) Multicentre Study. (2010) (0)
271 ANALYSIS OF THE FIRST 346 PATIENTS IN THE GERMAN ADRENOCORTICAL CARCINOMA REGISTRY (2007) (0)
Missing effect of etomidate on testosterone secretion in man (1986) (0)
123I-Iodometomidate as a radiotracer for the evaluation of adrenal tumours and adrenocortical carcinoma (2008) (0)
[Ascites with a blind spot]. (1995) (0)
Multihormonal response to CRH in Cushing's disease - a paradigm for pituitary cross-talk? (1988) (0)
Abstract 3111: Reverse Epidemiology in Chronic Heart Failure: Cumulative Predictive Power of Classical Cardiovascular Risk Factors (2008) (0)
Evidence for intraadrenal feed back regulation of steroidogenesis (2004) (0)
Mitotane induces a concentration-dependent impairment of platelet aggregation in patients with adrenocortical carcinoma (2008) (0)
Foreword by the Editors (2000) (0)
The German Society of Endocrinology (2009) (0)
[Cushing syndrome: diagnosis and therapy]. (1999) (0)
Urinary steroid profiling demonstrates induction of CYP3A4 and inhibition of 5alpha-reductase by mitotane treatment for adrenocortical carcinoma (2012) (0)
Towards a European Guideline for the treatment of hyponatremia (2012) (0)
High-rose 17 beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat (1999) (0)
Changes in mid-regional pro-atrial natriuretic peptide during thirsting separate patients with diabetes insipidus from those with primary polydipsia (2015) (0)
Vanishing bone: Stabilisation of Gorham-Stout disease during antiresorptive therapy (2003) (0)
Combined pituitary hormone deficiency (CPHD) with adult-onset corticotropin deficiency but without evidence for PROP-1 or HESX1 mutations (2003) (0)
The role of FDG-PET in patients with adrenocortical cancer (2007) (0)
Phenoxybenzamine, urapidil and nitrendipine for prevention of hypertensive crisis in a rat model for acute and chronic norepinephrine excess (2007) (0)
I-123-Iodometomidate for adrenal imaging -- First clinical experience (2007) (0)
Is isolated ACTH deficiency associated with a specific autoimmune thyropathy (2005) (0)
Copy number alterations and loss of heterozygosity in cortisol-secreting adrenocortical adenomas using SNP arrays: evidence of new candidate genes and pathways. (2012) (0)
Endocrine gland-derived vascular endothelial growth factor and its receptors in adrenocortical carcinoma (2009) (0)
The German Adrenocortical Carcinoma (ACC) Registry – establishment and first results (2004) (0)
The notch ligand Jagged1 is up-regulated in adrenocortical carcinomas and might induce NOTCH1 signaling pathway activation (2015) (0)
DIFFERENTIAL DIAGNOSIS OF PRIMARY ALDOSTERONISM SUBTYPES USING ADRENAL VEIN SAMPLING: EVALUATION OF THE GERMANS CONNʼS REGISTRY: 4D.07: (2010) (0)
92296783 Measurement of skin thickness by ultrasound in patients with endocrine disorders and osteoporosis (1993) (0)
Pre-clinical evaluation of the multitargeted tyrosin kinase inhibitor sunitinib in the treatment of adrenocortical carcinoma (ACC) (2007) (0)
188. Effect of cyproheptadine and clemastine on plasma cortisol in normal persons and in patients with Cushing's syndrome (1978) (0)
Potent adrenostatic activity of etomidate derivatives developed for adrenal imaging (2005) (0)
[123I]Iodometomidate imaging in adrenocortical carcinoma: Evaluation of 58 patients (2013) (0)
Surgical approach to primary hyperparathyroidism – impact of preoperative findings on surgical strategy: minimally invasive vs. conventional parathyroidectomy (2004) (0)
Differential expression of protein kinase A catalytic and regulatory subunits in adrenocortical adenomas (2016) (0)
[Differential diagnosis of tumor-associated hypoglycemia--exemplified by an insulinoma and a hemangiopericytoma. Case reports and review of the literature]. (1988) (0)
Dialysis / Cardiovascular complications (2011) (0)
[A 47-year-old patient with paroxysmal arterial hypertension and gastric tumors]. (2012) (0)
[Malignant tumors of the adrenal cortex]. (2002) (0)
Influence of morphine and naloxone on CRF-induced ACTH and ir-β 3-endorphin release (1986) (0)
The New Molecular Landscape of Cushing's (2015) (0)
Abstract LB-182: Constitutive activation of PRKACA in adrenal Cushing's syndrome (2014) (0)
Differential expression of the PKA subunits in adrenocortical adenomas (2015) (0)
131I-Iodometomidate radiotherapy for metastatic adrenocortical carcinoma - A new treatment option? (2008) (0)
No evidence for hepatic conversion of dehydroepiandrosterone sulfate (DHEAS) to DHEA – in vivo and in vitro studies (2004) (0)
[Adrenal cortex insufficiency: diagnosis and therapy]. (1999) (0)
Prevalence of neoplasms in patients with primary aldosteronism (2015) (0)
The LaHeF1-Y1 mouse as a model organism for in vivo evaluation of 123I-iodometomidate as radiotracer for adrenal imaging (2006) (0)
Isolated ACTH deficiency as a cause of impaired well-being in patients with primary hypothyroidism (2008) (0)
Cardiac Function in Adrenal Insufficiency — An Echocardiographic Study (1989) (0)
Imaging adrenal lesions with I-123-Iodometomidate: Semiquantitative and qualitative assessment (2012) (0)
Contents, Vol. 47, 1997 (1997) (0)
The effect of a TRB-3 knockdown on cholesterol absorption in THP-1 cells and macrophages (2013) (0)
Management of adrenal crisis – targets, limits and realities (2014) (0)
Perioperative hemodynamic stability in patients with pheochromocytoma – laparoscopic vs. open surgery (2005) (0)
Comparison of different test systems for the screening of inhibitors of CYP11B enzymes (2008) (0)
[Endocrinology update--II]. (1996) (0)
LONG-TERM OUTCOME OF LAPAROSCOPIC VERSUS OPEN ADRENALECTOMY FOR ADRENOCORTICAL CANCER (2009) (0)
[123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first in vivo experience (2007) (0)
Sunitinib decreases adrenocortical cancer cell proliferation and specifically inhibits adrenal steroidogenesis (2010) (0)
University of Birmingham Molecular and clinical evidence for an ARMC5 tumor syndrome (2016) (0)
Diagnosis of SIAD: Fractional urate excretion closes the diagnostic gap in hyponatremic patients on diuretics (2008) (0)
Neuroimmunomodulation Editors Induction by Cytokines of the Pattern of Pituitary Hormone 2 Secretion in Infection Impairment of Adrenocortical Function Associated with 14 Increased Plasma Tumor Necrosis Factor-alpha and Interleu- Kin-6 Concentrations in African Trypanosomiasis Release of Immunoreact (0)
[123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma (2008) (0)
Early interrenal (adrenal) development is independent of pituitary function in the zebrafish (2005) (0)
[Osteoporosis therapy. A pluralistic approach]. (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bruno Allolio?

Bruno Allolio is affiliated with the following schools: